Old Web
English
Sign In
Acemap
>
Paper
>
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, phase 1/2 trial
2016
Padmanee Sharma
Margaret K. Callahan
Petri Bono
Joseph S Kim
Pavlina Spiliopoulou
Emiliano Calvo
Rathi N. Pillai
Patrick A. Ott
Filippo de Braud
Michael A. Morse
Dung T. Le
Dirk Jaeger
Emily T Chan
Chris Harbison
Chen-Sheng Lin
Marina Tschaika
Alex Azrilevich
Jonathan E. Rosenberg
Keywords:
Nivolumab
Oncology
Metastatic Urothelial Carcinoma
Internal medicine
Medicine
Checkmate
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]